Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. 2009

Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
Department of Pathology, Medical Center, Clemenshospital Münster, Düesbergweg 128, D-48153 Münster, Germany. email@patho-muenster.de

OBJECTIVE To investigate the role of tumor infiltrating lymphocytes (TIL) in primary hepatocellular and cholangiolar carcinomas of the liver. METHODS Immunohistochemical analysis was performed including antibodies to CD3, CD4, CD8, CD20, CD56 and TIA-1 in formalin-fixed and paraffin-embedded tissue of 35 liver resection specimens of hepatocellular or cholangiocellular carcinomas. Semiquantitative evaluation was performed with emphasis on the area of the tumor itself and of the tumor/liver interface. RESULTS All hepatocellular carcinomas showed infiltration of lymphocytes predominantly around the tumor in the tumor/liver interface consisting mainly of CD3+ CD4+ T lymphocytes [164.3/10 high power fields (HPF)] and in the tumor itself of CD8+ cells (54.9/10 HPF). Cholangiocarcinomas contained a heterogeneous amount of TIL, composed mainly of CD3+ T cells with a predominance of CD8+ cells in the tumor tissue (52.6/10 HPF) and of CD4+ cells in the interface region (223.1/10 HPF). CD56+ cells of the innate immune system were scarce. There was no significant difference between hepatocellular or cholangiolar carcinoma. No correlation with the clinicopathological data was seen. CONCLUSIONS Liver TIL consists of intratumoral CD8+ T cells and peritumoral CD4+ T cells independent of histogenetic origin. Different functions of lymphocytes in these regions seem possible.

UI MeSH Term Description Entries
D007107 Immune System The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components. Immune Systems,System, Immune,Systems, Immune
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
December 2010, International journal of clinical oncology,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
August 1992, Japanese journal of clinical oncology,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
December 2010, International journal of clinical oncology,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
January 2007, Hepato-gastroenterology,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
December 2010, International journal of clinical oncology,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
January 2022, World journal of clinical cases,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
December 2018, Medicine,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
May 2007, Journal of gastroenterology and hepatology,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
April 1998, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Hans-Udo Kasper, and Uta Drebber, and Dirk-Ludger Stippel, and Hans-Peter Dienes, and Anton Gillessen
January 2021, OncoTargets and therapy,
Copied contents to your clipboard!